Arcus Biosciences, Inc.
RCUS· NYSE
RCUSArcus Biosciences, Inc.
Filed Aug 6, 2019 · 10-Q · 37 days after period end · 0001564590-19-029385
| Metric | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|
| Revenue | $1.75M | $1.25M | — |
| Net Income | -$28.09M | -$13.53M | -$9.55M |
| EPS Diluted | -$0.64 | -$0.32 | -$5.64 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Arcus Biosciences, Inc. · CIK 1724521 · Engraved from SEC EDGAR
ended Jun 30, 2019 · filed Aug 6, 2019 · 37 d after period end
